Zinfandel grants Takeda exclusive, worldwide rights to develop and commercialize an assay that detects variants of the TOMM40 gene for assessing Alzheimer's disease risk

Zinfandel Pharmaceuticals Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Takeda Pharmaceutical Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced